List of Rexahn Pharmaceuticals patents

List of Rexahn Pharmaceuticals patents

List of Attabotics patents

List of Stion patents

List of Ocean Tomo patents

Companies in the Regenerative medicine industry

Biotechnology companies in New York

Patents where

Current Assignee

Name

is

Rexahn Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9533958 Process or the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-Enyl)-1H-pyrimidin-2-one	Patent 9533958 was granted and assigned to Rexahn Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	9533958	January 3, 2017
	‌ US Patent 9782410 Fluorocyclopentenylcytosine methods of use	Patent 9782410 was granted and assigned to Rexahn Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	9782410	October 10, 2017
	‌ US Patent 10278971 Fluorocyclopentenylcytosine methods of use	Patent 10278971 was granted and assigned to Rexahn Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	10278971	May 7, 2019
	‌ US Patent 9713615 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds	Patent 9713615 was granted and assigned to Rexahn Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	9713615	July 25, 2017
	‌ US Patent 9969698 Quinoxalinyl-piperazinamide methods of use	Patent 9969698 was granted and assigned to Rexahn Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	9969698	May 15, 2018
	‌ US Patent 7388014 Quinazoline derivatives and therapeutic use thereof	Patent 7388014 was granted and assigned to Rexahn Pharmaceuticals on June, 2008 by the United States Patent and Trademark Office.		Rexahn Pharmaceuticals		United States Patent and Trademark Office	7388014	June 17, 2008
	‌ US Patent 10570101 Quinoxalinyl-piperazinamide methods of use	Patent 10570101 was granted and assigned to Rexahn Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	10570101	February 25, 2020
	‌ US Patent 10052321 Nanoparticulate compositions and formulations of piperazine compounds	Patent 10052321 was granted and assigned to Rexahn Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	10052321	August 21, 2018
	‌ US Patent 9150520 Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one	Patent 9150520 was granted and assigned to Rexahn Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	9150520	October 6, 2015
	‌ US Patent 8846110 Polymeric systems for the delivery of anticancer drugs	Patent 8846110 was granted and assigned to Rexahn Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.		Rexahn Pharmaceuticals		United States Patent and Trademark Office	8846110	September 30, 2014
	‌ US Patent 9193707 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds	Patent 9193707 was granted and assigned to Rexahn Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.		Rexahn Pharmaceuticals		United States Patent and Trademark Office	9193707	November 24, 2015
	‌ US Patent 9920016 Process for the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one	Patent 9920016 was granted and assigned to Rexahn Pharmaceuticals on March, 2018 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	9920016	March 20, 2018
	‌ US Patent 9744167 Nanoparticulate compositions and formulations of piperazine compounds	Patent 9744167 was granted and assigned to Rexahn Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals		United States Patent and Trademark Office	9744167	August 29, 2017
	‌ US Patent 8034829 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof	Patent 8034829 was granted and assigned to Rexahn Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office.		Rexahn Pharmaceuticals		United States Patent and Trademark Office	8034829	October 11, 2011
	‌ US Patent 8314123 5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof	Patent 8314123 was granted and assigned to Rexahn Pharmaceuticals on November, 2012 by the United States Patent and Trademark Office.		Rexahn Pharmaceuticals		United States Patent and Trademark Office	8314123	November 20, 2012

15 results

0 selected

15 results

0 selected